Who
Roberto Wandenkolk Vieira
President, Oncology
Company insider
Files Form 4 as: President, Oncology, Corcept Therapeutics.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $13.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2026
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $180K8,333 at $21.63 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $126K1,100 at $114.52 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $241K2,086 at $115.73 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $600K5,147 at $116.59 | filing |
| 2 Oct 2026filed 5 Oct 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,333 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $30K296 at $100.82 | filing |
| 16 Sep 2026filed 18 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $30K296 at $100.82 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $644K5,621 at $114.58 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $141K1,225 at $115.44 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —58,333 at $0.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $12K102 at $113.38 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —58,333 at $0.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $1.3M58,333 at $21.63 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $2.6M23,600 at $109.35 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $2.6M23,770 at $110.70 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $171K1,537 at $111.37 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $109K974 at $112.40 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $183K1,606 at $113.72 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $12K102 at $113.38 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $1.3M58,333 at $21.63 | filing |
News
No headline names them, or the companies they trade most, lately.